Hajime Maeda

4.7k citations
80 papers · 2.5k indexed · h-index 24
Topics
Diabetes Treatment and Management (14 papers)Diabetes Management and Research (10 papers)Heart Failure Treatment and Management (5 papers)
Partner nations
JapanUnited StatesItaly

In The Last Decade

Hajime Maeda

76 papers receiving 2.4k citations

Peers

Hajime Maeda
Comparison fields: 5 of 118
  • Surgery 801
  • Pulmonary and Respiratory Medicine 652
  • Neurology 502
  • Epidemiology 447
  • Oncology 413
Replace Hideki Sakai with:
Hideki Sakai Japan
Hiroshi Nihei Japan
Tetsuya Kaneko Japan
Yan Guo China
Muriel Mathonnet France
Koichiro Abe Japan
Gregory Kouraklis Greece
Qing Li China
Xin Zhang China
Hajime Maeda relative to Hideki Sakai Japan Hideki Sakai's profile →
Citations per field
00.5×1.7×
Hideki Sakai · 1×
Citations per year

Countries citing papers authored by Hajime Maeda

Since Specialization
Citations

This map shows the geographic impact of Hajime Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Maeda more than expected).

Fields of papers citing papers by Hajime Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Maeda. The network helps show where Hajime Maeda may publish in the future.

Co-authorship network of co-authors of Hajime Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Maeda. A scholar is included among the top collaborators of Hajime Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Maeda. Hajime Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 37
2 7
3 1
4 7
5 17
6 12
7 24
8 30
9 1
10 37
11 1
12 3
13 216
14 49
15 88
16 11
17 3
18 155
19 86
20 1

About Hajime Maeda

Hajime Maeda is a scholar working on Endocrinology, Diabetes and Metabolism, Anatomy and Pulmonary and Respiratory Medicine, having authored 80 papers that have together received 2.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Diabetes Management and Research (10 papers) and Heart Failure Treatment and Management (5 papers). The work is most often cited by research in Hepatology (366 citations), Neurology (502 citations) and Endocrinology, Diabetes and Metabolism (406 citations). Hajime Maeda has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Mitsunori Ohta, Akihide Matsumura, Meinoshin Okumura, Katsuhiro Nakagawa, Hikaru Matsuda, Tadaaki Eimoto, H. Tada, Hisashi Tateyama, Akira Masaoka and Masayoshi Inoue. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026